Baraldi PG - Search Results

1

Synthesis and structure activity relationship investigation of triazolo[1,5-a]pyrimidines as CB2 cannabinoid receptor inverse agonists.

Aghazadeh Tabrizi M, Baraldi PG, Ruggiero E, Saponaro G, Baraldi S, Poli G, Tuccinardi T, Ravani A, Vincenzi F, Borea PA, Varani K. Aghazadeh Tabrizi M, et al. Among authors: baraldi s, baraldi pg. Eur J Med Chem. 2016 May 4;113:11-27. doi: 10.1016/j.ejmech.2016.02.032. Epub 2016 Feb 16. Eur J Med Chem. 2016. PMID: 26922225

2

7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility.

Baraldi PG, Cacciari B, Romagnoli R, Spalluto G, Monopoli A, Ongini E, Varani K, Borea PA. Baraldi PG, et al. J Med Chem. 2002 Jan 3;45(1):115-26. doi: 10.1021/jm010924c. J Med Chem. 2002. PMID: 11754583

3

Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A(3) adenosine receptor antagonists.

Baraldi PG, Cacciari B, Moro S, Spalluto G, Pastorin G, Da Ros T, Klotz KN, Varani K, Gessi S, Borea PA. Baraldi PG, et al. J Med Chem. 2002 Feb 14;45(4):770-80. doi: 10.1021/jm0109614. J Med Chem. 2002. PMID: 11831890

4

Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.

Baraldi PG, Fruttarolo F, Tabrizi MA, Preti D, Romagnoli R, El-Kashef H, Moorman A, Varani K, Gessi S, Merighi S, Borea PA. Baraldi PG, et al. J Med Chem. 2003 Mar 27;46(7):1229-41. doi: 10.1021/jm021023m. J Med Chem. 2003. PMID: 12646033

5

Recent developments in the field of A2A and A3 adenosine receptor antagonists.

Baraldi PG, Tabrizi MA, Bovero A, Avitabile B, Preti D, Fruttarolo F, Romagnoli R, Varani K, Borea PA. Baraldi PG, et al. Eur J Med Chem. 2003 Apr;38(4):367-82. doi: 10.1016/s0223-5234(03)00042-4. Eur J Med Chem. 2003. PMID: 12750024

6

New strategies for the synthesis of A3 adenosine receptor antagonists.

Baraldi PG, Bovero A, Fruttarolo F, Romagnoli R, Tabrizi MA, Preti D, Varani K, Borea PA, Moorman AR. Baraldi PG, et al. Bioorg Med Chem. 2003 Sep 15;11(19):4161-9. doi: 10.1016/s0968-0896(03)00484-x. Bioorg Med Chem. 2003. PMID: 12951147

7

Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigation.

Pastorin G, Da Ros T, Spalluto G, Deflorian F, Moro S, Cacciari B, Baraldi PG, Gessi S, Varani K, Borea PA. Pastorin G, et al. Among authors: baraldi pg. J Med Chem. 2003 Sep 25;46(20):4287-96. doi: 10.1021/jm030852k. J Med Chem. 2003. PMID: 13678407

8

Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.

Baraldi PG, Tabrizi MA, Preti D, Bovero A, Romagnoli R, Fruttarolo F, Zaid NA, Moorman AR, Varani K, Gessi S, Merighi S, Borea PA. Baraldi PG, et al. J Med Chem. 2004 Mar 11;47(6):1434-47. doi: 10.1021/jm0309654. J Med Chem. 2004. PMID: 14998332

9

Synthesis and biological evaluation of novel N6-[4-(substituted)sulfonamidophenylcarbamoyl]adenosine-5'-uronamides as A3 adenosine receptor agonists.

Baraldi PG, Fruttarolo F, Tabrizi MA, Romagnoli R, Preti D, Bovero A, Pineda de Las Infantas MJ, Moorman A, Varani K, Borea PA. Baraldi PG, et al. J Med Chem. 2004 Oct 21;47(22):5535-40. doi: 10.1021/jm0408161. J Med Chem. 2004. PMID: 15481989

10

Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A3 adenosine receptor antagonists: pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as a key study.

Moro S, Braiuca P, Deflorian F, Ferrari C, Pastorin G, Cacciari B, Baraldi PG, Varani K, Borea PA, Spalluto G. Moro S, et al. Among authors: baraldi pg. J Med Chem. 2005 Jan 13;48(1):152-62. doi: 10.1021/jm049662f. J Med Chem. 2005. PMID: 15634009

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

247 results

Search Page